Get to know our clinical trials

Trial of amivantamab FOLFIRI compared to cetuximab/bevacizumab FOLFIRI in patients with recurrent, unresectable or metastatic colorectal cancer with KRAS/NRAS and wild-type BRAF who have received prior chemotherapy.

Imagen del Dr. Javier Rodríguez Rodríguez, especialista en Oncología Médica de la Clínica Universidad de Navarra. El Dr. Rodríguez se dedica al tratamiento y la investigación de tumores gastrointestinales (esofagogástricos y colorrectales)
Dr. Javier Rodríguez Curriculum
Codirector Medical Oncology Department
Navarre headquarters
Madrid headquarters
Cancer Center
Gastrointestinal Cancer Area
Status
In recruitment
headquarters
Pamplona/Madrid

Technical Summary

  • Code EudraCT: 2024-513853-66
  • Protocol number: 61186372COR3002

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION